Properties of 7ND-CCL2 are modulated upon fusion to Fc. (Q39385980)

11 September 2017

title

Properties of 7ND-CCL2 are modulated upon fusion to Fc. (English)

1 reference

11 September 2017

India C Severin

1

1 reference

11 September 2017

Adriano L S Souza

2

1 reference

11 September 2017

Jonathan H Davis

3

1 reference

11 September 2017

Najia Musolino

4

1 reference

11 September 2017

Matthias Mack

5

1 reference

11 September 2017

Christine A Power

6

1 reference

11 September 2017

Amanda E I Proudfoot

7

1 reference

11 September 2017

publication date

2 March 2012

1 reference

Protein Engineering Design and Selection

11 September 2017

published in

1 reference

11 September 2017

volume

25

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

213-222

1 reference

Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Chemokine regulation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

CCL2 (monocyte chemoattractant protein-1) and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Chemokine receptors: multifaceted therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

In vitro and in vivo properties of a dimeric bispecific single-chain antibody IgG-fusion protein for depletion of CCR2+ target cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

MCP-1: chemoattractant with a role beyond immunity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FPROTEIN%2FGZS008

21 January 2018

Identifiers

DOI

10.1093/PROTEIN/GZS008

1 reference

11 September 2017

1 reference